DESIGNED FOR

Primary Care Veterinarians and Specialists

Laverdia Bottles and Box
Tablet Icon

First targeted lymphoma treatment in a tablet

NOT cytotoxic
NOT bone marrow suppressive
Laverdia Pill
FDA Logo

Introducing the first FDA conditionally approved oral tablet to treat lymphoma in dogs

Trusted by over
1,000 veterinarians

  • For clients who decide against chemotherapy
  • First-line therapy with or without prednisone
Four veterinarians wearing Anivive face masks
Three Laverdia Pills

Designed to increase access to cancer care and help more of the 2,000 dogs diagnosed with canine lymphoma each day.

House Icon

Convenient at-home
administration

Two Circles Icon

Easy twice-weekly
dosing

Money Icon

Priced to make treatment
possible
to more patients.

Lymphoma Cell

Goes to work fast.

Effective medicine for all of your lymphoma patients.

LAVERDIA-CA1 has proven efficacy against B-cell and T-cell lymphoma, in both naïve and relapse cases.

Use Cases

Declined referralStethoscope Icon
SADIE
SPAYED FEMALE
12
AUSSIE/LAB
  • When prednisone alone is not enough.
  • Combine LAVERDIA-CA1 with steroids to turn palliative care into a targeted treatment plan designed to give clients more quality time with their dogs.
Aussie/Lab dog overlooking a desert scenery - Desktop ImageAussie/Lab dog overlooking a desert scenery - Mobile Image
Waiting for specialist appointmentStethoscope Icon
SCOUT
NEUTERED MALE
10
GOLDEN RETRIEVER
  • Don't let days pass without treatment.
  • Help prevent further advancements of cancer before chemotherapy starts. Unlike prednisone, LAVERDIA-CA1 does not create resistance to cytotoxic drugs.
Profile of German Shepherd smiling - Desktop ImageProfile of German Shepherd smiling - Mobile Image
Stopped chemotherapyStethoscope Icon
PEPPER
NEUTERED MALE
9
GERMAN SHEPHERD
  • Treatment doesn't have to stop.
  • LAVERDIA-CA1 can be used as a rescue therapy for patients that have relapsed or cannot continue traditional chemotherapy due to side effects.
Golden Retriever dog smiling - Desktop ImageGolden Retriever dog smiling - Mobile Image

Bea

4 year-old service dogB-cell lymphoma
"I didn't think she'd actually make it to her birthday, so I was excited when she did. This whole experience has allowed us to step back and slow down." Some days I say, "I'm just going to love Bea all day." We're definitely appreciating every minute with her."
Bea the Golden Retriever with a birthday hat on, looking at a birthday cookie.
Tablet Icon

Download new lymphoma treatment guidelines developed by veterinary oncologists.

Patient Profiles PDF

Breakthrough targeted treatment

LAVERDIA-CA1 is a Selective Inhibitor of Nuclear Export (SINE) that binds to XPO1 to block the transport of tumor suppressor proteins and induce apoptosis in cancer cells.

Technology proven in human healthcare.First use in veterinary medicine.

XPO1 with TSPs, moving
through nuclear pore

Laverdia

XPO1 blocked by
LAVERDIA-CA1

Laverdia

Growing collection
of TSP in nucleus

Laverdia
Device Icon

LAVERDIA-CA1
mechanism of action

Watch how it works
Laverdia Pills spread out - DesktopLaverdia Pills spread out - Mobile

LAVERDIA-CA1 makes it possible for more clients to pursue treatment.

Treatment as low as

$3 - 11

PER DAY
Laverdia Kit Box

Sign up to receive more information about LAVERDIA-CA1

Register Now

Tablet Icon

Read more product literature

Package Insert

Product Detailer

Client Brochure

Research Papers
Tablet Icon

Request more information, please contact an Anivive representative

Contact@anivive.com1-833-ANIVIVEFind Your Rep
Laverdia

LAVERDIA-CA1

verdinexor

Now available to
veterinarians